Short and long-term respiratory outcomes in neonates diagnosed with ventilator-associated pneumonia (VAP)

被引：0
|
作者：
Dell'Orto, V. G. [1 ]
Simunek-Zupan, V. [1 ]
Loddo, C. [1 ]
Rafik, B. A. [1 ]
Mike, D. L. Daniele [1 ]
机构：
[1] South Paris Univ Hosp, APHP, Med Ctr A Beclere, Neonatal Intaens Care Unit, Clamart, France
来源：
EUROPEAN JOURNAL OF PEDIATRICS | 2016年 / 175卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
967
引用
下载
收藏
页码：1747 / 1748
页数：2
相关论文
共 50 条
  • [31] Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis
    Tsaganos, Thomas
    Raftogiannis, Maria
    Pratikaki, Maria
    Christodoulou, Sofia
    Kotanidou, Anastasia
    Papadomichelakis, Evangelos
    Armaganidis, Apostolos
    Routsi, Christina
    Giamarellos-Bourboulis, Evangelos J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3640 - 3646
  • [32] Ventilator-Associated Pneumonia among Elderly Medicare Beneficiaries in Long-Term Care Hospitals
    Buczko, William
    HEALTH CARE FINANCING REVIEW, 2009, 31 (01): : 1 - 10
  • [33] Ventilator-associated pneumonia (VAP) A Risk already at the Time of Anesthetic Induction
    Vetter, L.
    Konrad, C.
    Schuepfer, G.
    Rossi, M.
    ANAESTHESIST, 2017, 66 (02): : 122 - 127
  • [34] MORTALITY AND CAUSE OF DEATH IN VENTILATOR-ASSOCIATED PNEUMONIA (VAP) DUE TO PSEUDOMONAS
    CROUCH, S
    WUNDERINK, R
    JONES, C
    LEEPER, K
    MEDURI, G
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A99 - A99
  • [35] Microfloral diversity in the lower respiratory tracts of neonates with bacterial infectious pneumonia combined with ventilator-associated pneumonia
    Lu, Wei
    Yu, Jia-Lin
    Li, Lu-Quan
    Lu, Qi
    Wang, Zheng-Li
    Pan, Yun
    MOLECULAR MEDICINE REPORTS, 2016, 14 (06) : 5223 - 5230
  • [36] The Zap VAP Initiative: Empowering Staff to Eliminate Ventilator-Associated Pneumonia
    Yates, Andrea
    CRITICAL CARE NURSE, 2012, 32 (02) : E65 - E65
  • [37] Treatment of ventilator-associated pneumonia (VAP) due to multiresistant Acinetobacter baumannii
    Barrero-Almodovar, A
    Gallego-Lara, S
    Garnacho-Montero, J
    Ortiz-Leyba, C
    Jiménez-Jiménez, F
    Garcia-Garmendia, J
    INTENSIVE CARE MEDICINE, 2002, 28 : S191 - S191
  • [38] The function of probiotics on the treatment of ventilator-associated pneumonia (VAP): facts and gaps
    Karacaer, Feride
    Hamed, Imen
    Ozogul, Fatih
    Glew, Robert H.
    Ozcengiz, Dilek
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (09) : 1275 - 1285
  • [39] Ventilator-associated pneumonia (VAP) - Early and late-onset differences
    Dias, Margarida
    Marcal, Paulo
    Amaro, Piedade
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] Ventilator-associated pneumonia (VAP): Risk factors and outcome assessment.
    Sisson, JH
    Peterson, D
    Radkey, F
    Winfield, B
    Olsen, KM
    Patil, KD
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (09): : 699 - 699
12345